Full-Time
Reimbursement Manager
Local Infusion
51-200 employees
Ambulatory infusion centers for chronic therapies
No salary listed
Remote in USA + 1 more
More locations: Nashville, TN, USA
Remote
Bachelor's
 Accounting (1) |
|---|
Get referred to Local Infusion
See people who can refer or advise you
- A minimum of five years of collections, billing, and/or cash posting experience in the specialty infusion or oncology healthcare setting is required.
- Strong knowledge of payer requirements, claims processes, and denial management is required.
- Experience with billing systems, electronic health record systems, and clearinghouses is required.
- Strong analytical skills are required.
- Leadership, communication, and problem-solving skills are required.
- Manage the collections process for payer balances, setting targets for days sales outstanding and aged accounts receivable.
- Identify root causes of denials and underpayments and implement process improvements to reduce recurring issues.
- Oversee end-to-end billing operations, including charge capture, claims submission, and denial management.
- Monitor key performance indicators, including clean claim rate, denial rate, collection rate, and accounts receivable aging, and report trends to leadership.
- Supervise, train, and develop billing and collections staff and set individual and team performance goals.
- Ensure compliance with payer contracts, coding guidelines, and applicable regulations, including HIPAA and Centers for Medicare & Medicaid Services rules.
- Prepare monthly reporting and forecasts for revenue cycle performance.
- Lead audits and quality control related to billing practices.
- Report to the Director of Revenue Cycle.
- A bachelor's degree is preferred.
Local Infusion operates ambulatory infusion centers and coordinates infusion and injectable therapies for chronic autoimmune diseases like Crohn’s, MS, and rheumatoid arthritis. It uses a proprietary AI-powered platform to streamline referrals and care coordination, plus patient tools for scheduling, pricing transparency, and financial assistance. The approach reduces administrative work for clinicians and lowers overall costs, with centers offering private suites and flexible hours to improve patient experience. The company aims to expand accessible, affordable infusion care outside hospitals while growing its network and keeping personalized patient support.
Company Size
51-200
Company Stage
Series A
Total Funding
$14M
Headquarters
Nashville, Tennessee
Founded
2022
Get referred to Local Infusion
See people who can refer or advise you
Simplify's Take
What believers are saying
- March 2026 Winchester opening and July 2026 Avon lease show continued expansion.
- June 2025 raised $30 million Series B from Transformation Capital for growth.
- QIVIGY launch with Kedrion expands revenue and validates Local Infusion's operating model.
What critics are saying
- Local Infusion still depends on payer and manufacturer contracts for patient flow.
- The December 2025 Carolina Neurology acquisition exposes integration risk and clinician turnover.
- Infusion reimbursement pressure can crush margins if payors steer patients to hospitals.
What makes Local Infusion unique
- Woody Baum and Ashley Knapp built AI-driven referral workflows from 2022 inception.
- Local Infusion offers evening, weekend appointments and private suites across 45-plus locations.
- Kedrion chose Local Infusion first ambulatory site for QIVIGY distribution in 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Parental Leave
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 7%1 year growth
↑ 1%2 year growth
↑ 0%Local Infusion now open in Avon, Ohio. Avon, Ohio. July 16, 2026: Local Infusion leased 1,832 SF at 35516 Detroit Road in Avon, Ohio, marking the company's first location in Northeast Ohio. Located in Lorain County, the property is anchored by the Wyndham Avon and adjacent to Avon Commons. The property offers excellent visibility within the market, with more than 118,000 people residing within a five-mile radius. Local Infusion's new location is surrounded by national retailers including Costco Wholesale, Target, The Home Depot, Kohl's, HomeGoods, Marshalls, Bath & Body Works, Five Below, Michaels, and many more. Seth Marks, Senior Director at Goodman Real Estate Services Group LLC, represented Local Infusion in the transaction. Local Infusion is an infusion and healthcare company focused on raising the standard of infusion care. The company strives to improve patient outcomes through advanced technology, personalized care, and financial transparency. Goodman Real Estate Services Group LLC represents Local Infusion throughout Northern Ohio, providing market analysis, strategic planning, and transaction guidance to support the company's continued growth. To discuss commercial real estate opportunities with Local Infusion, please contact Seth Marks. Goodman Real Estate Services Group is a premier commercial real estate brokerage specializing in retail brokerage, leasing, development, investment sales, and tenant representation across the Midwest. Since 1998, Goodman Real Estate has combined deep market expertise, advanced technology, data-driven insights, and a highly collaborative team approach to deliver strategic real estate solutions that help clients maximize value and achieve long-term success. For more information about Goodman Real Estate Services Group LLC, visit Its Website or call 216.381.8200
Specialty infusion clinic announces Creekside Station as its first Winchester location. Local Infusion, a Nashville-based specialty infusion provider with more than 45 locations nationwide, will open its first Winchester clinic at Creekside Station in March. The new site marks the company's 12th location in Virginia. The provider has leased 2,962 square feet at the 126,304-square-foot lifestyle center, owned by Continental Realty Corporation (CRC). CRC's Kelsi Holman represented the landlord alongside Segall Group brokers Andrew Lynch and Andy Segall, while Billy Orlove of The Shopping Center Group represented the tenant. "Adding Local Infusion strengthens Creekside Station's growing mix of health and wellness providers," said Kristina O'Keefe, Senior Vice President of Retail Operations at CRC. Local Infusion delivers patient-centered care for a range of chronic conditions, including asthma, multiple sclerosis, and lupus, using an AI-driven platform designed to speed up treatment access. "Our new Winchester clinic expands infusion care options and supports local health systems," said CEO Woody Baum, noting the site's convenient location and accessibility. Located at 3103 Valley Avenue, Creekside Station is a 13-acre retail center featuring a mix of shops, restaurants, and services, with strong surrounding demographics and traffic. The property is part of the larger Creekside Town Center mixed-use community, which includes office space and new residential development underway. Full article from CityBiz here.
Local Infusion joins the QIVIGY(R) limited distribution network as the first Ambulatory Infusion Center. Local Infusion will expand its infusion offerings with the addition of QIVIGY(R)(Immune Globulin Intravenous, human-kthm) 10% liquid from Kedrion Biopharma NASHVILLE, Tenn. - Local Infusion, the fastest growing ambulatory infusion provider in the United States, today announced it is joining Kedrion Biopharma's limited distribution network for QIVIGY (immune globulin intravenous, human-kthm), a 10% intravenous immunoglobulin (IVIG) solution to treat adults with Primary Humoral Immunodeficiency (PI). QIVIGY was approved by the FDA in late 2025 and will be available for use in March 2026, giving patients a new option to replace deficient antibodies and reduce infection rates. Kedrion Biopharma selected Local Infusion for its unique capability to bring together infusion data, intelligent automation, and programmable care pathways to help patients get treated quicker, improve treatment adherence, and ultimately deliver better patient outcomes. "At Kedrion, our dedication to those affected by rare diseases drives everything we do," said Lynda Bowe, Vice President Corporate Accounts of Kedrion. "Working with Local Infusion, we are united in our goal to make QIVIGY available to more people living with Primary Humoral Immunodeficiency across more communities. Together, we can help ensure that patients get the therapies they need more conveniently and reliably." "Kedrion's decision to name Local Infusion as the first Ambulatory Infusion Center in its limited distribution network for QIVIGY is a testament to the high quality of care our patients receive," said Ashley Knapp, Co-Founder and Chief of Staff at Local Infusion. "Through this limited distribution network, patients receiving QIVIGY have a convenient, comfortable option that gets them to treatment faster." By joining the QIVIGY limited distribution network, Local Infusion continues to expand its patient-centered programs accelerating speed to treatment and patient outcomes in collaboration with manufacturers, healthcare providers, health systems, and payors nationwide. About Local Infusion Local Infusion is a leading health care and technology company dedicated to transforming the specialty infusion industry, because patients deserve better. By combining comfortable, patient-centered clinical care with a proprietary, AI-driven technology platform, Local Infusion accelerates access, simplifies workflows, and improves outcomes for everyone in the infusion journey - from patients and clinicians to health plans, health systems, employers, and pharma. With Local Infusion, every patient and every care team is fully supported, every step of the way. Learn more at www.mylocalinfusion.com. Local Infusion Media Contact Riley Steinmetz VP of Marketing [email protected]
Specialty Pharmacy news roundup: march 2026. The following are just a few of the many recent specialty pharmacy activities this past month. You can find even more news and insights by subscribing to AMI's Specialty Pharmacy Database. AOM Infusion, a leading provider of specialty infusion care and pharmacy services, announced that it has earned the Distinction in Immunoglobulin (Ig) Therapy from the Accreditation Commission for Health Care (ACHC) in collaboration with the Immunoglobulin National Society (IgNS). This distinction is designed to identify immunoglobulin therapy centers of excellence, and AOM is proud to be among the first infusion therapy providers nationwide to receive it. AOM Infusion announced it has joined Kedrion Biopharma's limited distribution network for QIVIGY, a new 10% immune globulin (Ig) liquid indicated for treatment of adults with Primary Humoral Immunodeficiency (PI). The addition of QIVIGY expands AOM's immune globulin portfolio and strengthens its ability to help patients and providers access innovative therapies for complex immune disorders. This announcement builds on AOM's recent collaboration with Kedrion for YIMMUGO, a 10% immune globulin liquid also indicated for the treatment of PI. CarepathRx announced a new statewide Ancillary Agreement with Humana Healthy Horizons in Ohio. This partnership significantly expands CarepathRx's reach, allowing the company to provide Home Infusion Therapy, Specialty Infusions, and Enteral Nutrition services to Medicaid members throughout the entire state. This collaboration reflects its ongoing commitment to delivering high-touch specialty pharmacy care exactly where patients need it most. Local Infusion, the fastest growing ambulatory infusion provider in the United States, announced it is joining Kedrion Biopharma's limited distribution network for QIVIGY (immune globulin intravenous, human-kthm), a 10% intravenous immunoglobulin (IVIG) solution to treat adults with Primary Humoral Immunodeficiency (PI). Lumicera Health Services, a leading specialty pharmacy solutions provider and Top 10 national specialty pharmacy, announced that it has earned URAC's Rare Disease Pharmacy Center of Excellence Certification. This premier, evidence-based certification recognizes specialty pharmacies demonstrating exceptional, high-touch care and advanced capabilities serving patients with rare and complex conditions. The designation builds on Lumicera's existing URAC Specialty Pharmacy Accreditation, further validating Lumicera's commitment to exceeding expectations for patients requiring specialized therapies and individualized support. Onco360, the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Corcept Therapeutics for LIFYORLI (relacorilant), which is indicated in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens, at least one of which included bevacizumab. Transition Pharmacy, Regalo Health's direct-to-patient pharmacy, has relocated its primary fulfillment operations from Trevose, Pennsylvania, to a new 18,000-square-foot purpose-built facility at 100 Corporate Drive in Montgomeryville. The move expands capacity and strengthens its ability to deliver timely, high-quality care nationwide. Located in a well-connected regional logistics hub, the new facility supports more efficient shipping coordination and improved on-time delivery performance. The expanded space is designed for high-volume pharmacy operations with enhanced infrastructure. UVA Health has opened Pharmacy Central Services - a critical hub for UVA Health University Medical Center including UVA Health Children's; and UVA Health Culpeper, Haymarket, and Prince William Medical Centers in Northern Virginia. Continuing to support all three of its UVA Health strategic plan goals of expanding its excellence, cultivating healthy communities, and strengthening its foundation - Pharmacy Central Services widens its reach across Virginia, and to more than a dozen other states from Florida to Massachusetts.
/PRNewswire/ -- Tinsley Medical Practice Brokers is pleased to announce the successful sale of Carolina Neurology of Spartanburg, LLC to Local Infusion, a...